About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | PK and Safety of SI-722 in IC/BPS

PK and Safety of SI-722 in IC/BPS

NCT04208087·5 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Seikagaku Corporation

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Males or females, ≥18 and ≤80 years of age
A score of 19 or greater on the Bladder Pain/Interstitial Cystitis Symptom Score (BPIC-SS)

You may not be if

Urinary tract infection ≤30 days
Treatment with intravesical therapy ≤60 days
Treatment with any opioid therapy ≤7 days
History of bladder hydrodistension ≤3 months
Has cancer or a past history of any cancer ≤5 years
Body mass index (BMI) ≥40 kg/m2

The record

StatusCompleted

PhasePhase 1–2

Taking part33

StartedMar 2020

UpdatedDec 29, 2023

Conditions

Interstitial Cystitis Bladder Pain Syndrome

Where5

American Institute of Research
Los Angeles, California, United States
TriValley Urology Medical Group
Murrieta, California, United States
Premier Medical Associates
The Villages, Florida, United States